A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2011
12/21/2011	CN101940551B 一种巯基化壳聚糖季胺盐自组装纳米粒、其制备方法及应用 One kind of thiolated chitosan nanoparticles self-assembled quaternary ammonium salt, its preparation method and application
12/21/2011	CN101822833B 含有茶碱类药物和他汀类药物的药物组合物 The pharmaceutical compositions containing theophylline drugs and statins in
12/20/2011	US8080635 Non-functional P2X7 receptor
12/20/2011	US8080554 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
12/20/2011	US8080553 Methods and reagents for the treatment of immunoinflammatory disorders
12/20/2011	US8080551 HIV inhibiting pyrimidines derivatives
12/20/2011	US8080263 Dispersion for pulmonary delivery of a bioactive agent
12/20/2011	US8080241 Viruses for the treatment of cellular proliferative disorders
12/20/2011	CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide
12/20/2011	CA2524665C Drug delivery system
12/20/2011	CA2483464C Method for treating obesity
12/20/2011	CA2468562C Hydrazonopyrazole derivatives and their use as therapeutics
12/16/2011	DE202011105747U1 Mundspray/Mundwasser zur Gewichtsreduzierung Mouth spray / mouthwash to reduce weight
12/15/2011	WO2011156757A1 Combination of anti-hcv compounds with ribavirin for the treatment of hcv
12/15/2011	WO2011155579A1 ANTI-Trop-2 ANTIBODY
12/15/2011	WO2011134478A3 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
12/15/2011	WO2011133521A3 Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306540 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110306018 Methods For Improving Pregnancy Outcomes
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	DE102010032590A1 Pharmaceutical composition for in situ treatment of inflammatory and infective injuries at all positions comprises antibiotics, antifungal antibiotic in saccharose, and optionally dexamethasone, starch, preservative and filler
12/15/2011	DE102010026883A1 Transdermal system useful e.g. for indication of breast cancer with progesterone-receptor positive status, comprises e.g. aromatase inhibitor, active substance puller protection layer, active substance reservoir
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394646A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
12/14/2011	EP2394639A1 Hyperthermic technologies and therapeutic uses thereof
12/14/2011	EP2393915A1 Method of producing progenitor cells from differentiated cells
12/14/2011	EP2393494A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
12/14/2011	EP2393492A1 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
12/14/2011	EP2393490A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
12/14/2011	EP1742638B1 Composition comprising a diuretic and cardiac glycoside for the treatment of dna viral infections of the eye
12/14/2011	EP1513529B1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/14/2011	EP1458367B1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
12/14/2011	CN1835741B 包括罗格列酮和另一种抗糖尿病药的新组合物 Including rosiglitazone and another anti-diabetic drugs new compositions
12/14/2011	CN1460013B 局部凝胶给药体系 Topical gel delivery system
12/14/2011	CN102277427A miR-200b在制备治疗炎症性肠病纤维化疾病药物中的应用 miR-200b in the manufacture of the drug treatment of inflammatory bowel disease in fibrotic diseases
12/14/2011	CN102276606A 8-[{1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基]-8-苯基-1,7-二氮杂-螺[4.5]癸-2-酮的甲苯磺酸盐及其制备方法 8 - [{1- (3,5-bis - (trifluoromethyl) phenyl) - ethoxy} - methyl] -8-phenyl-1,7-diaza - spiro [4.5] dec- 2-one tosylate and preparation method
12/14/2011	CN102274518A Erk抑制剂与lxr激动剂组合药物对动脉硬化的防治 Erk inhibitors lxr agonist drug prevention and treatment of atherosclerosis
12/14/2011	CN102274517A 治疗帕金森病的方法 The method of treatment for Parkinson's disease
12/14/2011	CN102274516A 含有大分子的持续释放眼内植入物及相关方法 Material and associated method for a sustained release intraocular implant containing macromer
12/14/2011	CN102274515A 一种含孟鲁司特和他汀类药物的药物组合物 The pharmaceutical compositions containing montelukast and statin drugs
12/14/2011	CN102274514A 一种用于预防和治疗2型糖尿病及并发症的药物组合物 A method for the prevention and treatment of type 2 diabetes and complications of a pharmaceutical composition
12/14/2011	CN102274513A ERK1/2抑制剂通过刺激巨噬细胞干扰素γ表达抑制肿瘤生长 ERK1 / 2 inhibitor by stimulating interferon-γ expression of macrophage tumor growth inhibition
12/14/2011	CN102274512A LXR激动剂刺激巨噬细胞干扰素γ表达、抑制肿瘤生长 LXR agonists to stimulate expression of macrophage interferon γ, inhibition of tumor growth
12/14/2011	CN102274511A 一种用于治疗病毒性肝炎的药物组合物 A pharmaceutical composition for the treatment of viral hepatitis
12/14/2011	CN102274488A 一种治疗或预防癌症的药物 A medicament for the treatment or prevention of cancer
12/14/2011	CN102274390A 用于高雄激素型多囊卵巢综合征的药物组合物 Pharmaceutical compositions for polycystic ovary syndrome, hyperandrogenism
12/14/2011	CN102274347A 抗癌组合物及其应用 Anticancer compositions and their use
12/14/2011	CN102274183A 一种多囊脂质体制备方法和应用 A multi-sac liposome preparation methods and applications
12/14/2011	CN102274175A 纳米脂质立方晶制剂及其制备方法和应用 Nanolipid cubic its preparation method and application
12/14/2011	CN102274160A 用于治疗对抗高血压药的抗药性和相关病症的方法和制剂 For the treatment of antihypertensive drug resistance and related disorders methods and formulations
12/14/2011	CN102274159A 一种经皮渗透给药的维甲酸类药物组合物及其制备方法 Percutaneous penetration of retinoic acid administered pharmaceutical compositions and methods for preparing
12/14/2011	CN102274157A 适宜老年人使用的药用凝胶制剂及其制备方法 Medicinal gel preparation and preparation method suitable for the elderly use
12/14/2011	CN101874784B 析出结晶药物缓控释微球粒及其制备方法 Precipitation of crystalline drug controlled release microsphere and its preparation method
12/14/2011	CN101822635B 组合物在制备原位液晶血管栓塞剂中的应用 The composition used in the preparation of in-situ liquid embolization agent
12/14/2011	CN101732328B 治疗猪附红细胞体病的药物组合物、注射液及其制备方法 Treatment of swine eperythrozoonosis pharmaceutical composition, injection and its preparation method
12/14/2011	CN101642568B 一种红景天组合物 Rhodiola one kind of composition
12/14/2011	CN101505755B 抗癌药耐性克服剂 Overcoming resistance to anticancer drug agent
12/14/2011	CN101313894B 质子泵抑制剂组合物冻干粉针剂 Proton pump inhibitor composition freeze-dried powder
12/14/2011	CN101305982B 局部凝胶给药体系 Topical gel delivery system
12/14/2011	CN101069685B 固体口服剂型药物 The solid oral dosage form pharmaceutical
12/13/2011	US8076373 Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
12/13/2011	US8076319 Treatment of conditions relating to hormone deficiencies by administration of progestins
12/13/2011	US8076317 administering contraceptives comprising hormones in cycles
12/13/2011	US8076316 Steroid compounds and formulations
12/13/2011	US8076096 Alteration of cell membrane with FasL
12/13/2011	US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy
12/13/2011	US8076059 Adjuvant capable of specifically activating the adaptive immune response
12/13/2011	US8075917 Composition for solubilization of paclitaxel and preparation method thereof
12/13/2011	US8075914 Controlled release melatonin
12/13/2011	US8075892 Treatment with anti-ErbB2 antibodies
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/13/2011	CA2530938C Compounds, formulations, and methods for treating or preventing rosacea
12/13/2011	CA2492287C Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
12/13/2011	CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances
12/13/2011	CA2425316C A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
12/13/2011	CA2392666C Dextrin containing compositions for prevention of adhesions
12/13/2011	CA2386954C Methods of treating vascular diseases characterized by nitric oxide insufficiency
12/08/2011	WO2011152803A1 Water soluble formulation comprising a combination of amlodipine and a statin
12/08/2011	WO2011152721A1 Derivatives of pantothenic acid and their use for the treatment of malaria
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011151403A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/08/2011	WO2011151359A1 Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
12/08/2011	WO2011150944A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases
12/08/2011	WO2011042902A3 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
12/08/2011	WO2011012912A3 New granulating process and thus prepared granulate
12/08/2011	US20110301231 Lipase inhibiting composition
12/08/2011	US20110301158 Aryl carbonyl derivatives as therapeutic agents
12/08/2011	US20110301127 Methods of reducing microbial resistance to drugs
12/08/2011	US20110300533 Yeast Screens for Treatment of Human Disease
12/08/2011	US20110300129 Systems and methods for enhancing vaccine efficacy
12/08/2011	US20110300125 Compositions and methods for combined therapy of disease
12/08/2011	CA2796620A1 Injectable formulation
12/08/2011	CA2793601A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/07/2011	EP2392677A2 Combined use of prame inhibitors and hdac inhibitors
12/07/2011	EP2392355A1 Staining composition

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1151